Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...
Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid ...
The gambling industry is a high-stakes arena—not just for players but for money launderers exploiting its vulnerabilities.
The Government is moving to reduce the regulatory burden on New Zealand businesses by improving the Anti-Money Laundering and Countering Financing of ...
Banks in Cyprus must implement increased due diligence measures when conducting background checks on politically exposed ...
Singapore and Hong Kong—two of Asia’s most prominent private banking hubs—are at the forefront of implementing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results